“Metabolism of Antiepileptic Drugs”, 143-151, R.H. Levey,Ed., Raven Press, New York (1984). |
Bialer et al., Int. J. Pharmaceutics, 20: 53-63 (1984). |
Bialer et al., Biopharmaceutics and Drug Disposition, 6: 401-411 (1985). |
Bialer et al., Israel J. Med. Sci., 20: 46-49 (1984). |
Abstract of Collins, et al., “Extended Release Formulations of Anticonvulsant Medications Clinical Pharmacokinetics and Therapeutic Advantages”, CNS Drugs, New Zeland, 2000, 14/3 (203-212). |
Abstract of Bialer, et al., “Criteria to Assess in Vivo Performance and Bioequivalence of Generic Controlled-Release Formulations of Carbamazepine”, Epilepsia, United States, 1998, 39/5 (513-519). |
Abstract of Chun, et al., “Multiple-dose Evaluation of the Absorption Characteristics of Divalproex Sodium Tablets, a Delayed-Release Preparation of Valproate, in Healthy Volunteers”, Clinical Drug Investigation, New Zealand, 1995, 10/1, (40-47). |
Abstract of Bressolle, et al., “A Double Weibull Input Function Describes the Complex Absorption of Sustained-Release Oral Sodium Valproate”, Journal of Pharmaceutical Sciences, United States, 1994, 83/10 (1461-1464). |
Abstract of Hussein, et al., “Pharmacokinetic of Valproate after Multiple-dose Oral and Intravenous Infusion Administration: Gastrointestinal-related Diurnal Variation”, Journal of Clinical Pharmacology, United States, 1994, 37/7 (754-759). |
Abstract of Wilder, et al., “Gastrointestinal Tolerance of Divalproex Sodium”, Neurology, United States, 1983, 33/6 (808-811). |
Abstract of Wilder, et al., “Twice-daily Dosing of Valproate with Divalproex”, Clinical Pharmacology and Therapeutics, United States, 1983, 34/4 (501-504). |
Freitag, et al., “Depakote ER in Migraine Prophylaxis”, Abstract No. S07.003, Nuerology 54 Apr. 2000 (Suppl 3), p. A14. |
Collins, et al., “Depakote CR: Biopharmaceutical and Pharmacokinetic Studies of a New Formulation for Once Daily Dosing”, Neurology, vol. 50(4), Supplement 4, Apr. 1998, p. A426. |
Samara, et al., “Bioavailability of a Controlled-Release Formulation of Depakote”, No. 3.053, Epilepsia, vol. 38, Suppl. 8, 1997. |
Cavanaugh, et al., “Effect of Food on the Bioavailability of a Controlled Release Formulation of Depakote Under Multiple Dose Conditions”, No. 2.002, Epilepsia, vol. 38, Suppl. 8, 1997. |
Physicians' Desk Reference, 54th Edition, 2000, Depakene Capsules, pp. 426-427, published by Medical Economics Company, Inc. |
Physicians' Desk Reference, 54th Edition, 2000, Depakote Tablets, pp. 431-437, published by Medical Economics Company, Inc. |